Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

24.81
-0.3800-1.51%
Post-market: 24.80-0.0100-0.04%19:59 EDT
Volume:642.96K
Turnover:16.10M
Market Cap:1.11B
PE:-8.84
High:25.50
Open:25.30
Low:24.60
Close:25.19
52wk High:27.64
52wk Low:11.16
Shares:44.93M
Float Shares:42.20M
Volume Ratio:0.60
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8063
EPS(LYR):-2.1529
ROE:-15.57%
ROA:2.69%
PB:1.47
PE(LYR):-11.52

Loading ...

Is Pacira BioSciences, Inc. (PCRX) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
Mar 03

Earnings Update: Here's Why Analysts Just Lifted Their Pacira BioSciences, Inc. (NASDAQ:PCRX) Price Target To US$31.71

Simply Wall St.
·
Mar 02

Pacira price target raised to $24 from $17 at Barclays

TIPRANKS
·
Mar 01

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
Mar 01

Stock Track | Pacira Pharmaceuticals Plummets 5% as Commercial and Pipeline Execution Uncertainty Weighs on Outlook

Stock Track
·
Mar 01

Q4 2024 Pacira Biosciences Inc Earnings Call

Thomson Reuters StreetEvents
·
Feb 28

RBC Capital Adjusts Pacira Biosciences Price Target to $22 From $18, Maintains Sector Perform Rating

MT Newswires Live
·
Feb 28

Pacira BioSciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 28

Pacira Pharmaceuticals: Undervalued with Strong Growth Potential and Legal Protections Against Generic Competition

TIPRANKS
·
Feb 28

Pacira BioSciences Inc (PCRX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com
·
Feb 28

Pacira BioSciences Buys Remaining 81% Stake of GQ Bio Therapeutics

Dow Jones
·
Feb 28

Pacira (PCRX) Tops Q4 Earnings Estimates

Zacks
·
Feb 28

Pacira: Q4 Earnings Snapshot

Associated Press Finance
·
Feb 28

Pacira Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 28

Pacira reports Q4 non-GAAP EPS 96c, consensus 83c

TIPRANKS
·
Feb 28

Pacira BioSciences Q4 Adj $0.91 Beats $0.84 Estimate, Sales $187.25M Beat $184.36M Estimate

Benzinga
·
Feb 28

BRIEF-Pacira Biosciences FY Adjusted EBITDA USD 224 Million Vs. IBES Estimate USD 222 Million

Reuters
·
Feb 28

Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results

GlobeNewswire
·
Feb 28

Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio

GlobeNewswire
·
Feb 28

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March

GlobeNewswire
·
Feb 26